Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma

Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 376-382

  Jin No, Kenji ^a   Tanimizu, Masahito ^a   Hyodo, Ichinosuke ^a   Nishikawa, Yoshiyuki ^a   Hosokawa, Yasushi ^a   Doi, Toshihiko ^a   Endo, Hisashi ^a   Yamashita, Tetsuji ^b   Okada, Yoshio ^c  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Circulating VEGF; Hepatocellular carcinoma; Metastasis

Indexed keywords

TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031775790     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050099     Document Type: Article

References (29)

1. Klagsbrun M, Sasse J, Sullvian R, et al. Human tumor cells synthesize an endothelial cell growth factor that is tructurally related to basic fibroblast growth factor. Proc Natl Acad Sci USA 1986;83:2448-2452.
2. Schrieber AB, Winkler ME, Derynck R. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science 1986;232:1250-1253.
3. Barrette P, Travers M, Luqmani Y, et al. Transforming growth factors in human breast cancer: Clinical correlates. Br J Cancer 1990;61:612-617.
4. Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and early relapse in primary breast cancer. Jpn J Cancer Res 1994; 85:1045-1049.
5. Folkman J, Shing Y. Angiogenesis. J Biol Hem 1992;267:10931-10934.
6. Reynolds K, Farzaneh F, Collins WP, et al. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86:1234-1238.
7. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fins family. Oncogene 1990;5:519-524.
8. De Varies C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;555:989-991.
9. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-1309.
10. Mattern J, Koomägi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer 1996;73:931-934.
11. Anthony JG, Graziella AJ, Kathi T, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 1996;78:454-460.
12. Inoue K, Ozeki Y, Suganuma T, et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression. Cancer 1997;79:206-213.
13. Plate KH, Breire G, Weich HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
14. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of gastrointestinal tract. Cancer Res 1993;53:4727-4735.
15. Suzuki K, Hayashi M, Miyamaoto Y, et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 1996;56:3004-3009.
16. Mise M, Arii S, Higashituji H, Furutani M, et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996; 23:455-464.
17. Shirai Y, Kawata S, Tamura S, et al. Plasma transforming growth factor β 1 in patients with hepatocellular carcinoma. Cancer 1994;73:2275-2279.
18. Tsushima H, Kawata S, Tamura S, et al. High levels of transforming growth factor β 1 in patients with colorectal cancer: Association with disease progression. Gastroenterology 1996;110: 375-382.
19. Fujimoto K, Ichimori Y, Yamaguchi H, et al. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn J Cancer Res. 1995;86:182-186.
20. Yamamoto Y, Toi M, Kondo S, et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 1996;2:821-826.
21. Jin-no K, Tanimizu M, Hyodo I, et al. The plasma basic fibroblast growth factor increase with progression of chronic liver disease. J Gastroenerol 1997;32:119-121.
22. Jin-no K, Tanimizu M, Hyodo I, et al. The circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma. Cancer 1997; in press.
23. Sobin LH, Wittekind CK (eds) International Union Against Cancer (UICC). TNM Classification of malignant tumors, 5th ed. New York: Wiley-Liss, 1997;74-77.
24. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963;44:239-242.
25. Yamane A, Seetharam L, Yamaguchi S, A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Fit tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 1994; 9:2683-2690.
26. Möhle R, Green D, Moore MAS, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci, USA 1997;94:663-668.
27. Hino M, Nishizaa Y, Tagawa S, et al. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 1995;217:475-481.
28. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990;211:277-287.
29. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88:277-285.